The market for ablation devices stands to grow the most among all nonvascular interventional radiology devices in the U.S. over the next several years, the Millennium Research Group concludes in a new report. The analyst firm sees the overall ablation device market in this space--a sector that include radiofrequency ablation, cryoablation and microwave ablation devices--hitting $295 million by 2017. What's the driver here? These devices are less invasive than surgery as a way to treat liver, prostate, kidney and lung cancer, Millennium notes, something that is relevant as those soft-tissue cancers rise in frequency. And their use benefits a number of smaller medical devices in the space, the report notes, including AngioDynamics and Microsulis. Release